Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current assets:
Cash	$ 27,082	$ 2,658
Accounts receivable	223	223
Due from related party		27,177
Total current assets	27,305	30,058
Fixed assets, net of accumulated depreciation of $30,785 and $19,685, respectively	15,321	26,121
Total assets	42,626	56,179
Current liabilities
Accounts payable and accrued expenses	567,598	455,684
Accrued interest	131,741	82,584
Deferred revenue	25,000
Notes payable	171,630	212,530
Notes payable - related party	8,458	8,458
Convertible notes payable, net of discounts of $61,842 and $150,062, respectively	328,361	233,296
Derivative liability	505,647	264,648
Total current liabilities	1,738,435	1,257,200
Shareholders (deficit)
Series A preferred stock; $0.01 par value; 1,100 shares authorized; 100 shares issued and outstanding at December 31, 2013 and December 31, 2012, respectively
Series B preferred stock; $0.01 par value; 100 shares authorized; shares 100 shares issued and outstanding as of December 31, 2013 and December 31, 2012, respectively	1	1
Common stock; $0.001 par value; 5,000,000,000 shares authorized; 335,994,983 and 183,583 shares authorized and issued at December 31, 2013 and December 31, 2012, respectively	335,995	183
Common shares sold and unissued, 1,666 at December 31, 2013 and December 31, 2012, respectively	2	2
Additional paid-in capital	19,322,140	6,326,359
Common stock payable	50,000
Deferred compensation	(6,770,833)
Other comprehensive income (loss)	(85,502)	(220,695)
(Deficit) accumulated during the development stage	(14,547,612)	(7,306,871)
Total shareholders (deficit)	(1,695,809)	(1,201,021)
Total liabilities and shareholders (deficit)	$ 42,626	$ 56,179